Is It Time To Think Beyond mRNA For COVID Vaccines? FDA Advisors Intrigued by Novavax As Booster

 
• By Sarah Karlin-Smith
  
novavax covid prototype vax
Some FDA vaccine advisors suggested looking beyond mRNA vaccines for COVID-19 boosters. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet